0000899243-20-035009.txt : 20201223
0000899243-20-035009.hdr.sgml : 20201223
20201223172635
ACCESSION NUMBER: 0000899243-20-035009
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201222
FILED AS OF DATE: 20201223
DATE AS OF CHANGE: 20201223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hofmeister Robert
CENTRAL INDEX KEY: 0001760102
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38811
FILM NUMBER: 201413649
MAIL ADDRESS:
STREET 1: C/O TCR2 THERAPEUTICS INC.
STREET 2: 100 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TCR2 THERAPEUTICS INC.
CENTRAL INDEX KEY: 0001750019
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 474152751
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-949-5200
MAIL ADDRESS:
STREET 1: 100 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-12-22
0
0001750019
TCR2 THERAPEUTICS INC.
TCRR
0001760102
Hofmeister Robert
TCR2 THERAPEUTICS INC.
100 BINNEY STREET
CAMBRIDGE
MA
02142
0
1
0
0
Chief Scientific Officer
Common Stock
2020-12-22
4
M
0
7000
0.74
A
45850
D
Stock Option (Right to Buy)
0.74
2020-12-22
4
M
0
7000
0.00
D
2026-12-13
Common Stock
7000
28732
D
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
25% of this option shall vest and become exercisable on December 13, 2017, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.
/s/ Margaret Siegel as Attorney-in-Fact
2020-12-23